Access

Letter

Nature 457, 887-891 (12 February 2009) | doi:10.1038/nature07619; Received 16 July 2008; Accepted 7 November 2008; Published online 7 January 2009

Open Innovation Challenges

Runx1 is required for the endothelial to haematopoietic cell transition but not thereafter

Michael J. Chen1,2,4, Tomomasa Yokomizo3, Brandon M. Zeigler1, Elaine Dzierzak3 & Nancy A. Speck1,4

  1. Department of Biochemistry,
  2. Department of Genetics, Dartmouth Medical School, Hanover, New Hampshire 03755, USA
  3. Department of Cell Biology and Genetics, Erasmus Medical Center, 3000 CA Rotterdam, The Netherlands
  4. Present address: Abramson Family Cancer Research Institute and Department of Cell and Developmental Biology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA.

Correspondence to: Nancy A. Speck1,4 Correspondence and requests for materials should be addressed to N.A.S. (Email: nancyas@exchange.upenn.edu).

Top

Haematopoietic stem cells (HSCs) are the founder cells of the adult haematopoietic system, and thus knowledge of the molecular program directing their generation during development is important for regenerative haematopoietic strategies. Runx1 is a pivotal transcription factor required for HSC generation in the vascular regions of the mouse conceptus—the aorta, vitelline and umbilical arteries, yolk sac and placenta1, 2. It is thought that HSCs emerge from vascular endothelial cells through the formation of intra-arterial clusters3 and that Runx1 functions during the transition from 'haemogenic endothelium' to HSCs4, 5. Here we show by conditional deletion that Runx1 activity in vascular-endothelial-cadherin-positive endothelial cells is indeed essential for intra-arterial cluster, haematopoietic progenitor and HSC formation in mice. In contrast, Runx1 is not required in cells expressing Vav1, one of the first pan-haematopoietic genes expressed in HSCs. Collectively these data show that Runx1 function is essential in endothelial cells for haematopoietic progenitor and HSC formation from the vasculature, but its requirement ends once or before Vav is expressed.

  1. Department of Biochemistry,
  2. Department of Genetics, Dartmouth Medical School, Hanover, New Hampshire 03755, USA
  3. Department of Cell Biology and Genetics, Erasmus Medical Center, 3000 CA Rotterdam, The Netherlands
  4. Present address: Abramson Family Cancer Research Institute and Department of Cell and Developmental Biology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA.

Correspondence to: Nancy A. Speck1,4 Correspondence and requests for materials should be addressed to N.A.S. (Email: nancyas@exchange.upenn.edu).